Readily Available Tissue-Engineered Vascular Grafts Derived From Human Induced Pluripotent Stem Cells

Affiliations

• ¹ Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, U.S.A. (J.L., J.P., Y.H., X.S., M.R., M.W.E., C.W.A., Y.R., Y.Q.).
• ² Yale Stem Cell Center (J.L., J.P., Y.H., X.S., M.R., M.W.E., C.W.A., Y.R., L.E.N., Y.Q.).
• ³ Surgery (L.Q., G.T.).
• ⁴ Anesthesiology (M.H.K., J.W., Y.Y., L.E.N.).
• ⁵ Vascular Biology and Therapeutics Program, Yale School of Medicine (M.H.K., J.W., Y.Y., G.T., L.E.N., Y.Q.).
• ⁶ Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China (X.S.).
• ⁷ Cellular and Molecular Physiology (M.W.E.).
• ⁸ Pathology, Yale School of Medicine (C.W.A., Y.Q.).
• ⁹ Indiana Center for Regenerative Medicine and Engineering, Indiana University School of Medicine, Indianapolis, IN, U.S.A. (M.C.Y.).
• ¹⁰ Biomedical Engineering (L.E.N.).